ADIL:NASDAQ, Adial Pharmaceuticals, Inc.

Why ADIL stock rose on October 28

Adial Pharmaceuticals, Inc. rose 36.1% on Wednesday, October 28, 2026, on 83,085 shares. The headline around the move:

Oct 28: Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis

ADIL stock overview

Adial Pharmaceuticals, Inc. (ADIL:NASDAQ) closed at $5.05 on October 28, 2026, up 36.12% on the day. The stock trades 45.4% below its 52-week high of $9.25 and 285.5% above its 52-week low of $1.31. Over the past year, it lost 42.3%. Adial Pharmaceuticals, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price: $5.05
Day change: +36.12%
Volume: 83,085
Average volume: 56,620
Market cap: 13M+
52-week range: $1.31 – $9.25
50-day average: $4.75
200-day average: $3.24

Price action over the past year

In 252 trading sessions since October 28, 2025, ADIL closed higher on 101 days (40%). Its best day was June 11, 2026 (+37.96%) and its worst was February 4, 2026 (-23.81%). The stock moved 10% or more in a single session 22 times.

Recent signals

Oct 28, 2026: Hit a new 1-Month High of $5.05 (New Highs/Lows scanner)
Sep 30, 2026: News catalyst: Private Placement (News Catalysts scanner)

ADIL news

About Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders.

Similar stocks

Find more stocks like ADIL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.